Pacific Microdevices to Accelerate Biotech Innovation with help from Unlimit Ventures
An emerging biotech company revolutionizing molecular diagnostics, Pacific Microdevices serves the biotech community by developing cutting-edge microdevices and instrumentation designed to accelerate customer innovation and advance scientific discovery. Unlimit Ventures is proud to support Pacific Microdevices during this critical early stage of product development. Our involvement centers on helping define the physical design and user interaction form factor for optimal laboratory integration and establishing aggressive, but achievable milestones and development schedules.
Miniaturizing the Gold Standard in Molecular Testing
Pacific Microdevices' first product focuses on miniaturizing polymerase chain reaction (PCR)—the most common molecular test performed by the biomedical industry. Through an innovative combination of 3D printing and microfluidics technologies designed by scientists for scientists, their solution enables test labs to dramatically reduce time-to-result while maintaining the gold standard accuracy that PCR is renowned for, all at a lower cost per test.
This breakthrough technology promises to transform how research labs and biotech firms conduct molecular testing, making high-quality diagnostics faster, more accessible, and more affordable.
A Company to Watch
Pacific Microdevices is currently operating in stealth mode as they refine their technology and prepare for market entry. For more background on this exciting Whitworth University spinoff, read the recent news article from the Spokane Journal here.
Led by Pacific Microdevices CEO Philip Measor, we're thrilled to be part of their journey to make molecular diagnostics faster, more accessible, and more affordable for the global biotech community.
Want to learn more about how Unlimit Ventures can support your product development journey?